Salvage versus adjuvant radiotherapy after radical prostatectomy: Argument for adjuvant radiotherapy

Journal of the Canadian Urological Association

Volumn 3, Issue 3, 2009, Pages 241-244

  Chin, Joseph L ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70450161236     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.1081     Document Type: Article

References (25)

1. Bolla M, van Poppel H, Collette L, et al.; European Organization for Research and Treatment of Cancer. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005;366:572-574
2. Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006;296:2329-2335
3. Chin JL. Post-radical prostatectomy management options for the positive surgical margin: argument for adjuvant radiotherapy. Urol Oncol 2009;27:87-88
4. Morgan SC, Waldron TS, Eapen L, et al.; Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Program in Evidence-based Care. Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: a systematic review and meta-analysis. Radiother Oncol 2008;88:1-9.
5. Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow-up of a randomized clinical trial. J Urol. In press.
6. Swanson GP, Goldman B, Tangen CM, et al.; Southwest Oncology Group 8794. The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794. J Urol 2008;180:2453-2457
7. Teh BS, Bastasch MD, Mai WY, et al. Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins. J Urol 2006;175:2097-2101
8. Caraffini B, De Stefani A, Vitali E, et al. Postoperative radiotherapy after radical prostatectomy for prostate carcinoma: the experience of the Brescia Radium Institute. Radiol Med 2006;111:741-747
9. Pacholke HD, Wajsman Z, Algood CB, et al. Postoperative adjuvant and salvage radiotherapy for hemical relapse and survival prostate cancer: impact on freedom from biochemical relapse and survival. Urology 2004;64:982-986
10. Trabulsi EJ, Valicenti RK, Hanlon AL, et al. A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology 2008;72:1298-1302
11. Wadasaki K, Kaneyasu Y, Kenjo M, et al. Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Clin Oncol 2007;12:37-41.
12. Loeb S, Roehl KA, Viprakasit DP, et al. Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy. Eur Urol 2008;54:88-94.
13. Stephenson AJ, Scardino PT, Kattan MW, et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007;25:2035-2041
14. Lennernäs B, Edgren M, Häggman M, et al. Postoperative radiotherapy after prostatectomy - a review. Scand J Neprol Urol 2003;37:10-15
15. Pasquier D, Ballereau C. Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review. Int J Radiat Oncol Biol Phys 2008;72:972-979
16. Brooks JP, Albert PS, Wilder RB, et al. Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors. J Urol 2005;174:2204-2208
17. Pisansky TM, Kozelsky TF, Myers RP, et al. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy. J Urol 2000;163:845-850
18. Vees H, Buchegger F, Albrecht S, et al. 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (< 1 ng/mL) after radical prostatectomy. BJU Int 2007;99:1415-1420
19. Pucar D, Sella T, Schöder H. The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery. Curr Opin Urol 2008;18:87-97.
20. Bottke D, Wiegel T. pT3R1 prostate cancer: Immediate or delayed radiotherapy after radical prostatectomy? [article in German]. Urologe A 2008;47:1431-1435
21. Van Cangh PJ, Ricard F, Lorge F, et al. Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study. J Urol 1998;159:164-166
22. Feng MG, Hanlon AL, Pisansky TM, et al. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. J Urol 2005;174:2204-2208
23. Pinkawa M, Fischedick K, Asadpour B, et al. Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysis. Radiother Oncol 2008;88:135-139
24. Amos EH, Mendenhall WM, McCarty PJ, et al. Postoperative radiotherapy for locally advanced colon cancer. Ann Surg Oncol 1996;3:431-436
25. Chen AM, Granchi PJ, Garcia J, et al. Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 2007;67:982-987 (Pubitemid 46320095)